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Stabilization of proteins in delivery devices and design of ap-
propriate protein carriers are major research issues due to the
extreme sensitivity of proteins. Previously, negatively charged
nanoparticles, consisting of poly(lactic-co-glycolic acid) (PLGA)
and poly (styrene-co-4–styrene-sulfonate) (PSS), showed con-
siderably high loading capacity for positively charged model
protein lysozyme depending on the surface charge density of
nanoparticles. Chitosan coated lysozyme loaded layer-by-
layer protein delivery nanocarrier were prepared and the
influence of chitosan composition, concentration and initial
protein loading on the release and stability of nanoparticles
were investigated.
Nanoparticles were prepared by a solvent displacement
method. Loading with oppositely charged model protein ly-
sozyme and followed by chitosan coating were completed
through electrostatic interaction between oppositely charged
nanoparticle-protein, and nanoparticle-chitosan. Morphol-
ogy of nanoparticles was investigated using scanning electron
microscopy (SEM) and transmission electron microscopy (TEM).
At a ratio of PLGA to PSS 10% and initial theoretical lysozyme
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loading 10%, the effect of chitosan (CS) (150 kDa) concentra-
tion on the properties of the lysozyme loaded nanoparticles
is shown in Fig. 1. The results indicate that the concentration
of CS had a significant influence on the particle size and zeta-
potential of all the resulting formulations investigated. More
specifically, the size of the CS-coated nanoparticles linearly in-
creased upon addition of increasing amounts of CS from 244 nm
to 606 nm (R2 = 0.9671) within the range of chitosan concen-
trations from 0 to 1.92 mg/ml. The SEM and AFM images of
nanoparticles were shown in Fig. 2. In addition, dissociation
of lysozyme was dependent on polymer composite, irrespec-
tive of initial protein loading. Moreover, with this polymer
coating more stable particles were obtained in PBS, without
burst release within 24 hours. In light of these results, these
novel polymer coated protein loaded nanoparticles with layer-
by-layer nanostructure could be suggested as promising new
protein delivery systems with beneficial properties, i.e.
protection of protein, controlled release, stability, and com-
bined with potential properties of coated polymer.
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Fig. 1 – Size (Z-Ave) (A) and zeta-potential (ZP) (B) of lysozyme-loaded nanoparticles after incubation with chitosan (150 kDa)
solution at different concentrations (mean ± S.D., n = 3) (A) and SEM images of nanoparticles at the chitosan concentration
of 60 (A) and 120 μg/ml (B), respectively. TEM images of uncoated nanoparticles (C) and coated nanoparticles (D) at the
chitosan concentration of 120 μg/ml, respectively (B).
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